Market Overview:
The global prednisolone market is expected to grow at a CAGR of 5.5% from 2018 to 2030. Prednisolone is a synthetic glucocorticoid drug, which is used for the treatment of various medical conditions such as inflammation, rheumatoid arthritis, bell's palsy, acute lymphoblastic leukemia (ALL), autoimmune hepatitis, systemic lupus erythematosus (SLE), dermatomyositis, vasculitis and Crohn's disease. The oral solution segment accounted for the majority share of the global prednisolone market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to factors such as ease of use and better patient compliance compared with other dosage forms. The North America region dominates the global prednisolone market followed by Europe and Asia Pacific regions respectively.
Product Definition:
Prednisolone is a synthetic glucocorticoid drug that is mainly used to treat inflammatory conditions and autoimmune diseases.
Tables:
Tables are the most important raw materials used for the production of prednisolone. The demand and supply gap in this market is due to its limited usage as feedstock for manufacturing other chemicals, such as acetate esters, acrylates, and propionates. tables are manufactured by catalytic hydrogenation of ethylene which gives a mixture of C-10 & C-14 isomers.
Oral Solution:
Oral solution is a form of drug delivery system which involves the use of medication in liquid or solid form to treat diseases by mouth. The most common oral medications are anti-biotic, analgesic (pain killer), antibiotic, and antacid among others. Prednisolone is an oral solution that helps reduce inflammation and pain in case of osteoarthritis. It works by blocking the production of cytokines, which are responsible for causing pain.
Application Insights:
On the basis of application, the global prednisolone market has been segmented into inflammation, rheumatoid arthritis, acute lymphoblastic leukemia, autoimmune hepatitis, systemic lupus erythematosus, dermatomyositis and vasculitis. In 2017, the acute lymphoblastic leukemia segment dominated with a share of 24.1% in terms of revenue. This is owing to an increase in incidence rates for this condition coupled with high usage rates for treatment purposes. Prednisolone is one of the most commonly used drugs across all cancer types as it reduces inflammation and pain caused by these conditions without having any significant side effects or drug interactions associated with it.
The autoimmune hepatitis segment is expected to grow at a lucrative rate over the forecast period due to an increase in prevalence rates coupled with high usage levels for treatment purposes only (sulfasalazine).
Regional Analysis:
North America was the largest regional market in 2017 owing to high product demand for various chronic diseases. The region is expected to maintain its dominance throughout the forecast period on account of increasing R&D activities and presence of key players in this region. In addition, growing healthcare expenditure by government and private sectors is also one of the major factors contributing toward growth in North America.
Asia Pacific is anticipated to be the fastest-growing regional market during the forecast period due to rising product penetration for treating various disorders coupled with improving healthcare infrastructure & affordability in developing countries such as China & India. Moreover, an increase in disposable income levels will boost consumer spending on medication, which will further fuel growth over coming years.
Growth Factors:
- Increasing prevalence of autoimmune diseases and other respiratory disorders is expected to drive the growth of prednisolone market over the forecast period.
- Rising demand for prednisolone as an anti-inflammatory and immunosuppressive agent is another major factor anticipated to fuel the growth of this market in near future.
- Growing number of research studies on novel applications for prednisolone is projected to create new opportunities for this market in coming years.
- increasing geriatric population base is also expected to propel the demand for prednisolone in near future owing to higher incidence rate of respiratory disorders among them . 5) Technological advancements in manufacturing process are likely to result into reduction of production cost, thereby making Prednisolone more affordable and accessible across regions
Scope Of The Report
Report Attributes
Report Details
Report Title
Prednisolone Market Research Report
By Type
Tables, Oral Solution
By Application
Inflammation, Rheumatoid Arthritis, Bell's Palsy, Acute Lymphoblastic Leukemia, Autoimmune Hepatitis, Systemic Lupus Erythematosus, Dermatomyositis, Vasculitis, Crohn's Disease
By Companies
Sanofi, Symbiotec Pharma, Xianju Pharma, Wuhan DKY Technology, Shandong Taihua Bio &Tech, Mahima life Sciences, Add Biotec, Henan Lihua Pharmaceutical, Hunan Yuxin Pharmaceutical, TEVA, Pfizer, Pharmacia, Sandoz, Endo International, Wockhardt
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Prednisolone Market Report Segments:
The global Prednisolone market is segmented on the basis of:
Types
Tables, Oral Solution
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Inflammation, Rheumatoid Arthritis, Bell's Palsy, Acute Lymphoblastic Leukemia, Autoimmune Hepatitis, Systemic Lupus Erythematosus, Dermatomyositis, Vasculitis, Crohn's Disease
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Symbiotec Pharma
- Xianju Pharma
- Wuhan DKY Technology
- Shandong Taihua Bio &Tech
- Mahima life Sciences
- Add Biotec
- Henan Lihua Pharmaceutical
- Hunan Yuxin Pharmaceutical
- TEVA
- Pfizer
- Pharmacia
- Sandoz
- Endo International
- Wockhardt
Highlights of The Prednisolone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tables
- Oral Solution
- By Application:
- Inflammation
- Rheumatoid Arthritis
- Bell's Palsy
- Acute Lymphoblastic Leukemia
- Autoimmune Hepatitis
- Systemic Lupus Erythematosus
- Dermatomyositis
- Vasculitis
- Crohn's Disease
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prednisolone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Prednisolone is a corticosteroid medication that is used to treat a variety of conditions, including asthma, arthritis, and other inflammatory conditions. Prednisolone works by reducing inflammation and pain in the body.
Some of the key players operating in the prednisolone market are Sanofi, Symbiotec Pharma, Xianju Pharma, Wuhan DKY Technology, Shandong Taihua Bio &Tech, Mahima life Sciences, Add Biotec, Henan Lihua Pharmaceutical, Hunan Yuxin Pharmaceutical, TEVA, Pfizer, Pharmacia, Sandoz, Endo International, Wockhardt.
The prednisolone market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Prednisolone Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Prednisolone Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Prednisolone Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Prednisolone Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Prednisolone Market Size & Forecast, 2018-2028
4.5.1 Prednisolone Market Size and Y-o-Y Growth
4.5.2 Prednisolone Market Absolute $ Opportunity
Chapter 5 Global Prednisolone Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Prednisolone Market Size Forecast by Type
5.2.1 Tables
5.2.2 Oral Solution
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Prednisolone Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Prednisolone Market Size Forecast by Applications
6.2.1 Inflammation
6.2.2 Rheumatoid Arthritis
6.2.3 Bell's Palsy
6.2.4 Acute Lymphoblastic Leukemia
6.2.5 Autoimmune Hepatitis
6.2.6 Systemic Lupus Erythematosus
6.2.7 Dermatomyositis
6.2.8 Vasculitis
6.2.9 Crohn's Disease
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Prednisolone Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Prednisolone Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Prednisolone Analysis and Forecast
9.1 Introduction
9.2 North America Prednisolone Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Prednisolone Market Size Forecast by Type
9.6.1 Tables
9.6.2 Oral Solution
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Prednisolone Market Size Forecast by Applications
9.10.1 Inflammation
9.10.2 Rheumatoid Arthritis
9.10.3 Bell's Palsy
9.10.4 Acute Lymphoblastic Leukemia
9.10.5 Autoimmune Hepatitis
9.10.6 Systemic Lupus Erythematosus
9.10.7 Dermatomyositis
9.10.8 Vasculitis
9.10.9 Crohn's Disease
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Prednisolone Analysis and Forecast
10.1 Introduction
10.2 Europe Prednisolone Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Prednisolone Market Size Forecast by Type
10.6.1 Tables
10.6.2 Oral Solution
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Prednisolone Market Size Forecast by Applications
10.10.1 Inflammation
10.10.2 Rheumatoid Arthritis
10.10.3 Bell's Palsy
10.10.4 Acute Lymphoblastic Leukemia
10.10.5 Autoimmune Hepatitis
10.10.6 Systemic Lupus Erythematosus
10.10.7 Dermatomyositis
10.10.8 Vasculitis
10.10.9 Crohn's Disease
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Prednisolone Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Prednisolone Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Prednisolone Market Size Forecast by Type
11.6.1 Tables
11.6.2 Oral Solution
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Prednisolone Market Size Forecast by Applications
11.10.1 Inflammation
11.10.2 Rheumatoid Arthritis
11.10.3 Bell's Palsy
11.10.4 Acute Lymphoblastic Leukemia
11.10.5 Autoimmune Hepatitis
11.10.6 Systemic Lupus Erythematosus
11.10.7 Dermatomyositis
11.10.8 Vasculitis
11.10.9 Crohn's Disease
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Prednisolone Analysis and Forecast
12.1 Introduction
12.2 Latin America Prednisolone Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Prednisolone Market Size Forecast by Type
12.6.1 Tables
12.6.2 Oral Solution
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Prednisolone Market Size Forecast by Applications
12.10.1 Inflammation
12.10.2 Rheumatoid Arthritis
12.10.3 Bell's Palsy
12.10.4 Acute Lymphoblastic Leukemia
12.10.5 Autoimmune Hepatitis
12.10.6 Systemic Lupus Erythematosus
12.10.7 Dermatomyositis
12.10.8 Vasculitis
12.10.9 Crohn's Disease
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Prednisolone Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Prednisolone Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Prednisolone Market Size Forecast by Type
13.6.1 Tables
13.6.2 Oral Solution
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Prednisolone Market Size Forecast by Applications
13.10.1 Inflammation
13.10.2 Rheumatoid Arthritis
13.10.3 Bell's Palsy
13.10.4 Acute Lymphoblastic Leukemia
13.10.5 Autoimmune Hepatitis
13.10.6 Systemic Lupus Erythematosus
13.10.7 Dermatomyositis
13.10.8 Vasculitis
13.10.9 Crohn's Disease
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Prednisolone Market: Competitive Dashboard
14.2 Global Prednisolone Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Symbiotec Pharma
14.3.3 Xianju Pharma
14.3.4 Wuhan DKY Technology
14.3.5 Shandong Taihua Bio &Tech
14.3.6 Mahima life Sciences
14.3.7 Add Biotec
14.3.8 Henan Lihua Pharmaceutical
14.3.9 Hunan Yuxin Pharmaceutical
14.3.10 TEVA
14.3.11 Pfizer
14.3.12 Pharmacia
14.3.13 Sandoz
14.3.14 Endo International
14.3.15 Wockhardt
